Riskpilot← Back to searchSign inGet full accessredoxme AB
ABActiveOrg 5590211800Södra Grytsgatan 1 A 7226-3005Manufacture of other chemical products n.e.c. · NACE 2059Est. 201513 employees
Revenue 2025
SEK 27,1M
-9% vs 2024
EBITDA margin
9.5%
-71% vs 2024
Equity ratio
51.9%
Financial strength
Net profit 2025
SEK 1,2M
-77% vs 2024
| Revenue | SEK 27,1M | -9% |
| EBITDA | SEK 2,6M | -71% |
| Net profit | SEK 1,2M | -77% |
| Total assets | SEK 17,7M | -5% |
| Equity | SEK 9,2M | -7% |
| Employees | 13 | — |
Legal name
redoxme AB
Org number
5590211800
Legal form
Aktiebolag
NACE code
2059 · Manufacture of other chemical products n.e.c.
Founded
20 juli 2015
Share capital
SEK 50 000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Sätet för företaget kommer att vara i Sverige. Affärsverksamheten innefattar design, tillverkning och försäljning av högeffektiva laboratorie- och forskningsinstrument för en mängd olika användningsområden och applikationer. 1) elektrokroma apparater 2) solceller 3) energilagring 4) bränsleceller 5) korrosion 6) ektrolytbaserade transistorer 7) sensorer Utvecklande mätuppställningar kommer att distribueras genom en online-butik tillsammans med en vetenskapsblog som beskriver och marknadsför en modern praxis för mätningar och optimering av tunnfilmsmaterial och apparater.
Address
Södra Grytsgatan 1 A 7226-3005
Email
info@redox.me
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 376 | 3 032 | 5 235 | 11 521 | 16 212 | 21 946 | 29 821 | 27 114 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −31 | −31 | 104 | 844 | 719 | 681 | 1 655 | 6 113 | 8 870 | 2 589 |
| Depreciation & amort. | −0 | −0 | −0 | −3 | −14 | −34 | −89 | −146 | −207 | −438 |
| EBIT | −31 | −31 | 104 | 841 | 705 | 647 | 1 566 | 5 967 | 8 663 | 2 151 |
| Net financials | — | — | — | −22 | −28 | −51 | −18 | −17 | −16 | −47 |
| Profit before tax | −31 | −31 | 95 | 620 | 497 | 446 | 1 159 | 4 650 | 7 048 | 1 704 |
| Tax | −0 | −0 | −8 | −138 | −130 | −100 | −258 | −968 | −1 544 | −455 |
| Net profit | −31 | −31 | 87 | 482 | 367 | 346 | 901 | 3 682 | 5 504 | 1 249 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 50 | 56 | 197 | 1 414 | 2 343 | 4 239 | 7 311 | 15 392 | 18 680 | 17 705 |
| Equity | 50 | 56 | 142 | 624 | 696 | 1 072 | 1 935 | 4 405 | 9 919 | 9 186 |
| Long-term debt | 0 | 0 | 0 | 0 | 400 | 502 | 262 | 110 | 1 206 | 0 |
| Short-term debt | 0 | 0 | 44 | 580 | 857 | 2 126 | 4 184 | 8 646 | 3 725 | 4 289 |
| Total debt | — | — | 44 | 580 | 1 257 | 2 628 | 4 446 | 8 756 | 4 931 | 4 289 |
EBITDA margin
9.5%
This company
15.8%
Market median
-40% vs market
20162025
Equity ratio
51.9%
This company
38.2%
Market median
+36% vs market
20162025
Return on equity
13.6%
This company
18.4%
Market median
+26% vs market
20162025
Net profit margin
4.6%
This company
8.1%
Market median
-43% vs market
20162025
Asset turnover
1.53×
This company
1.12×
Market median
+37% vs market
20162025
Debt / equity
0.93×
This company
0.62×
Market median
+50% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-07-01 – 2016-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PT Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of redoxme AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Tobias Ericsson | Chief Auditor | 0 companies |
| Iwona Anna Bernacka-Wojcik | Deputy Board Member | 0 companies |
| Pawel Jerzy Wojcik | Board of Directors | 0 companies |